Orion Oyj
Develops, manufactures, and markets human and veterinary pharmaceuticals and APIs.
ORNAV | HE
Overview
Corporate Details
- ISIN(s):
- FI0009014377 (+1 more)
- LEI:
- 74370029VAHCXDR7B745
- Country:
- Finland
- Address:
- Orionintie 1, FI-02200 ESPOO
- Website:
- https://www.orion.fi/en/
- Sector:
- Manufacturing
Description
Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). The company's portfolio encompasses a wide range of products, including prescription drugs, generic medications, and over-the-counter (OTC) products. In addition to its proprietary and generic product lines for both human and animal health, Orion provides contract manufacturing and packaging services to other pharmaceutical entities. The company manages the entire pharmaceutical value chain, from research and development through to production and marketing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2010-06-17 06:51 |
20,138 Orion A-shares converted into B-shares
|
English | HTML • 1021 bytes | ||
| 2010-06-14 08:11 |
Orion upgrades full-year outlook for 2010
|
English | HTML • 3.4 KB | ||
| 2010-06-14 08:11 |
Orion parantaa näkymäarviotaan vuodelle 2010
|
Finnish | HTML • 3.2 KB | ||
| 2010-06-01 07:01 |
1,100,000 Orion A-shares converted into B-shares
|
English | HTML • 1.0 KB | ||
| 2010-06-01 07:01 |
1 100 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi
|
Finnish | HTML • 915 bytes | ||
| 2010-04-20 06:32 |
Deksmedetomidiinin faasi III -ohjelma valmistui myönteisin tuloksin
|
Finnish | HTML • 5.5 KB | ||
| 2010-04-20 06:31 |
Dexmedetomidine Phase III program completed with positive results
|
English | HTML • 5.1 KB | ||
| 2010-04-15 08:31 |
Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 2…
|
Finnish | HTML • 1.9 KB | ||
| 2010-04-15 08:31 |
Orion invites analysts and media to Q1 news conference on Tuesday 27 April 2010
|
English | HTML • 1.9 KB | ||
| 2010-04-01 10:37 |
Orion kommentoi FDA:n tiedotetta Stalevo-lääkkeestä
|
Finnish | HTML • 2.9 KB | ||
| 2010-04-01 10:37 |
Orion comments on FDA release on Stalevo
|
English | HTML • 2.8 KB | ||
| 2010-03-24 15:05 |
Orion Corporation: Matti Kavetvuo Vice Chairman of the Board of Directors. Comp…
|
English | HTML • 1.6 KB | ||
| 2010-03-24 15:05 |
Orion Oyj: hallituksen varapuheenjohtajaksi Matti Kavetvuo. Valiokuntien kokoon…
|
Finnish | HTML • 1.6 KB | ||
| 2010-03-24 14:30 |
Orion Corporation: Decisions by the AGM on 24 March 2010
|
English | HTML • 9.8 KB | ||
| 2010-03-11 10:30 |
Orion Corporation: Member of the Board of Directors of Orion Corporation Leena…
|
English | HTML • 873 bytes |
Automate Your Workflow. Get a real-time feed of all Orion Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orion Oyj
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orion Oyj via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
